PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-60

  1. 3,769 Posts.
    lightbulb Created with Sketch. 1548
    This was also written in the previous quarterly:

    “Research and development expenditure for the quarter was $21.9m compared to the previous quarter of $16.15m.

    The anticipated spend for Q2 FY24 is expected to be at a lower level to the previous two quarters. ”

    The forecasts are worth the paper they are written on.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $261.4K 990.7K

Buyers (Bids)

No. Vol. Price($)
1 9999 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 9445 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.